| 期刊論文1. | (2004)。DRUG CONSULTS: Taxanes-dose, infusion rate, and hypersensitivity under the title of Paxlitaxel。MICROMEDEX (R) Healthcare Series,119。 | 2. | Weinberg, J. M.、Egan, C.、Tangoren, I. A.、Li, L.、Laughinghouse, K. A.、Guzzo, C. A.(1997)。Generalized pustular dermatosis following paclitaxel therapy。Int J Dermatol,36,559-560。 | 3. | Young, P. C.、Montemarano, A. D.、Lee, N.、Sau, P.、Weiss, R. B.、James, W. D.(1996)。Hypersensitivity to paclitaxel manifested as a bullous fixed drug eruption。J Am Acad Dermatol,34,313-314。 | 4. | Roth, B. J.、Yeap, B. Y.、Wilding, G.、Kasimis, B.、McLeod, D.、Loehrer, P. J.(1993)。Taxol in advanced, hormone-refractory carcinoma of the prostate。Cancer,72,2457-2460。 | 5. | Peerboom, D. M.、Donehower, R. C.、Eisenhauer, E. A.(1993)。Successful re-treatment with Taxol after major hypersensitivity reactions。J Clin Oncol,11,885-890。 | 6. | Rayne, J. Y.、Holmes, F.、Cohen, P. R.、Gagel, R.(1996)。Severe mucocutaneous toxicity in a patient with hyperbilirubinemia。Southern Medical Journal,89(5),542-545。 | 7. | Beri, R. B.、Rosen, F. R.、Pacini, M. J.、Desai, S. R.(200402)。Severe dermatologic reactions at multiple sites after paclitaxel administration。The Annals of Pharmacotherapy,38,238-241。 | 8. | Laskin, M. S.、Lucchesi, K. J.、Morgan, M.(1993)。Paclitaxel rechallenge failure after a major hypersensity reaction。J Clin Oncol,11,2456-2457。 | 9. | Markman, M.(1997)。Simplified regiment for the prevention of paclitaxel-associated hypersensitivity reactions。Journal of Clinical Oncology,15,3517。 | 10. | Markman, M.(199907)。An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions。J Cancer Res Clin Oncol,125(7),427-429。 | 11. | Bookman, M. A.(1997)。Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions。Ann Oncol,8(6),611-614。 | 12. | Koppler, H.、Heymanns, J.、Weide, R.(200106)。Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions。Onkologie,24(3),283-285。 | 圖書1. | Mcevoy, G. K.(2004)。American Society of Health-system Pharmacists。 | 2. | (200106)。Package insert: Taxol (paclitaxel)。Miami, FL:IVAX Laboratories。 | 3. | Perry, M. C.、Weiss, R. B.。The Chemotherapy Sourcebook。 | 4. | Finley, R. S.、Balmer, C.。Concepts in Oncology Therapeutics。 | 5. | Dukes, M. N. G.、Aronson, J. K.(2000)。Meyler's Side Effects of Drugs。Amsterdam:Elsevier。 | 6. | Casciato, D. A.(2004)。Manual of Clinical Oncology。 | 7. | Chabner, B. A.(2001)。Cancer Chemotherapy & Biotherapy: Principles & Practices。 | 8. | Valley, A. W.、Balmer, C. M.(1985)。Pharmacotherapy。 | 9. | Rubin, S. C.(1996)。Chemotherapy of gynecologic cancers: Society of Gynecologic Oncologists handbook。 | |